Tapayan, Wishney A.

HRN: 21-54-42  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFUROXIME 750MG (VIAL)
07/23/2022
07/24/2022
IV
750mg
Q8
S/P LTCS

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines